ADVOCATE. CONNECT. INNOVATE.

Category Archives: Institute

2017 Year in Review: Poised for Growth & Success

The California Life Sciences Institute (CLSI) is wrapping up another year on a high note, and would like to express our sincere gratitude to the outstanding companies, volunteers, students, educators, partners, sponsors and others who have joined us to further bolster our thriving California life sciences ecosystem. During 2017, CLSI ‘s FAST and CARB-X accelerator … Continue reading 2017 Year in Review: Poised for Growth & Success

Fall 2017 FAST Closing Showcase Celebrates Eight Companies

CLSI celebrated key milestones at the Fall 2017 FAST Closing Showcase at Byers Auditorium in UCSF San Francisco on December 13, 2017. The Showcase marked the culmination of the Fall program and included presentations from eight graduating FAST companies: BioAmp Diagnostics, developing diagnostic assays that can detect antibiotics resistance directly in patient samples; Phi Therapeutics, … Continue reading Fall 2017 FAST Closing Showcase Celebrates Eight Companies

FAST, Fellow and CARB-X Updates December

FAST & Fellows Round-Up STATegics (FAST Fall 2017) is announced winner of the PharmaDirections JumpStart award Purigen Biosystems (FAST Spring 2015) appoints life science industry veteran Barney Saunders as CEO Read More GigaGen (FAST Spring 2015) CEO David Johnson will be presenting at 2017 Antibody Engineering & Therapeutics Meeting Read More CLSA Fellow AnimalBiome wins … Continue reading FAST, Fellow and CARB-X Updates December

Bio-Link Depot’s Grand Opening in Oakland

Donate Tax-Deductible Scientific Equipment and Supplies Bio-Link Depot celebrated the Grand Opening of its new Oakland, California location last month with record numbers of educators and researchers in attendance.  Since 2002, the Bio-Link Depot has connected educators and researchers with needed science supplies and equipment through its clearinghouse of biotech industry donations. Because of the … Continue reading Bio-Link Depot’s Grand Opening in Oakland

CLSI CARB-X Hosts Intensive Strategy Session for “Powered by CARB-X” Proteus IRC

The CLSI CARB-X team – Heather Shane, Steve Karp, and Amy Xu – hosted Powered by CARB-X company, Proteus IRC, for an intensive strategy session designed to help Proteus transition from a research consortium to a VC-backed entity. The three-day session drew 22 volunteer advisors from 20 different organizations – from as far as Washington, … Continue reading CLSI CARB-X Hosts Intensive Strategy Session for “Powered by CARB-X” Proteus IRC

CLSI Participates in BARDA Industry Days and the One Nucleus Leadership Seminar – Addressing Infectious Disease Challenges

Heather Shane, Executive Director of the California Life Sciences Institute’s (CLSI) CARB-X Accelerator, spoke in November on two occasions about CARB-X and CLSI’s role in helping to move companies that are addressing the problem of Antimicrobial Resistance (AMR) through the product development pipeline. Her first appearance was at BARDA Industry Days in Washington, DC, where … Continue reading CLSI Participates in BARDA Industry Days and the One Nucleus Leadership Seminar – Addressing Infectious Disease Challenges

FAST & Fellows Round Up

November 2017 Read the latest in FAST and Fellows news: Encellin’s (FAST Spring 2017) insulin-releasing implant for Type-1 Diabetes featured on NPR Read More LogicInk (FAST Spring 2017) announced their first product, LogicInk UV, an electronics-free temporary wearable powered by programmable ink Read More Eidos Therapeutics (FAST Spring 2016) initiates Phase 1 trial of AG10, … Continue reading FAST & Fellows Round Up

CARB-X Updates November 2017

Powered by CARB-X company Spero plans for $75M IPO for November 2nd (SPRO) Read More Inhibrx Wins CARB-X Award of up to $6.0M to Accelerate Development of its Novel Antibody, INBRX-111, to Treat Pseudomonas Infections Read More CARB-X backs Integrated Biotherapeutics to accelerate the development of a novel toxoid-based vaccine to prevent drug-resistant MRSA infections … Continue reading CARB-X Updates November 2017

CLSI Launches Innovation Series with Reimbursement Panel at Verily

October 24, 2017 The California Life Sciences Institute has launched a new Innovation Series that will focus on issues most pressing for life science startups from the very early to more advanced stage of development.  The inaugural session – Reimbursement 101 – took place on October 24 at Verily in South San Francisco and was sponsored … Continue reading CLSI Launches Innovation Series with Reimbursement Panel at Verily

CLSI Participates in Antimicrobial Resistance Panel at the 2017 BIO Investor Forum

  Heather Shane, Executive Director of the CLSI CARB-X accelerator, spoke at this year’s BIO Investor Forum in San Francisco at a panel on the Antimicrobial Resistance: New Research and Funding Opportunities. The panel sought to explore the growing threat of antimicrobial resistance (AMR), the economic challenges in developing these products, and the incentives proposed … Continue reading CLSI Participates in Antimicrobial Resistance Panel at the 2017 BIO Investor Forum